2220. Deputy Pádraig Rice asked the Minister for Health if her attention has been drawn to an equivalent hormone replacement therapy scheme in another jurisdiction (details supplied); if she will conduct an equality impact assessment; and if she will make a statement on the matter. [74723/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Pádraig Rice under the heading Medicinal Products.
43 questions match, newest first.
431. Deputy Pádraig Rice asked the Minister for Health to address the issue of access to oral immunotherapy for children with nut allergies; for an update in respect of the HSE senior leadership team’s decision on the medicine in question; and if she will make a statement on the matter. [73118/25]
442. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 609 of 23 September 2025, to clarify if a group were excluded from the costing for the free hormone replacement therapy (HRT) scheme; if so, to outline how, given the details of an internal communication in relation to the basis for the costing (details supplied); and if she will make a statement on the matter. [62378/25]
459. Deputy Pádraig Rice asked the Minister for Health the number of people on a waiting list for pre-exposure prophylaxis (PrEP) by clinic; and the wait time to be offered a new appointment in each clinic, in tabular form. [60783/25]
350. Deputy Pádraig Rice asked the Minister for Health the position in relation to a drug (details supplied); if it will be available through the HSE; and if she will make a statement on the matter. [55951/25]
1155. Deputy Pádraig Rice asked the Minister for Health if she will expedite approval and funding of a new drug (details supplied) to treat those living with Barakat Syndrome; and if she will make a statement on the matter. [47827/25]
2679. Deputy Pádraig Rice asked the Minister for Health if the Medicines Management Programme’s proposed reclassification of high protein (HP) oral nutrition supplements to list B will be suspended to allow the scientific data to be properly evaluated; if she is aware of thejoint position statement detailing the clinical, ethical, and economic concerns associated with this proposal endorsed by over500 healthcare prof…
2680. Deputy Pádraig Rice asked the Minister for Health if she will request that the Medicines Management Programme begins formal engagement with the Irish Society for Clinical Nutrition and Metabolism, the Irish Nutrition and Dietetic Institute and academic nutrition leaders to revise guidance on high-protein (HP) ONS products in line with international expert consensus; and if she will make a statement on the matte…
2882. Deputy Pádraig Rice asked the Minister for Health if her attention has been brought to the exclusion of transgender women from the free HRT scheme (details supplied); if she will re-examine the guidance issued to pharmacies to ensure that transgender women are not excluded from the scheme; and if she will make a statement on the matter. [42566/25]
865. Deputy Pádraig Rice asked the Minister for Health the timeline she is working towards to initiate the review of the drug reimbursement process; the patient advocacy representation that will be on the review; and if she will make a statement on the matter. [38733/25]
931. Deputy Pádraig Rice asked the Minister for Health the steps she will take to ensure that adults with spinal muscular atrophy receive access to approved medicines (details supplied); if she will engage in dialogue with stakeholders regarding the current age-based exclusion; and if she will make a statement on the matter. [32774/25]
1481. Deputy Pádraig Rice asked the Minister for Health the reason for the delay in commencing the inquiry into the historical licensing and use of sodium valproate; the work carried out to date; the timeline for formal commencement; and if she will make a statement on the matter. [29835/25]
1511. Deputy Pádraig Rice asked the Minister for Health the number of patients receiving biologics medicines for severe asthma in 2024 and to date in 2025; and the specific biologic medicines included, in tabular form. [29978/25]
1512. Deputy Pádraig Rice asked the Minister for Health the number of patients receiving biologic medicines for severe asthma in 2024 and to date in 2025, by health region and hospital, in tabular form. [29979/25]
1513. Deputy Pádraig Rice asked the Minister for Health the status of the commissioned managed access protocol necessary for the reimbursement of a severe asthma biologic medicine for patients with EOS level greater than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29980/25]
1514. Deputy Pádraig Rice asked the Minister for Health the status of the health technology assessment ongoing with the National Centre for Pharmacoeconomics for a biologic medicine to be used for severe asthma patients with EOS level less than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29981/25]
800. Deputy Pádraig Rice asked the Minister for Health if a drug will be made available to patients for certain types of gastric and gastroesophageal junction cancers under the HSE reimbursement scheme (details supplied); and if she will make a statement on the matter. [27684/25]
295. Deputy Pádraig Rice asked the Minister for Health if a drug (details supplied) will be made available to patients with biliary tract cancers; and if she will make a statement on the matter. [8436/25]